Schacterle Amy bought ABOS
January 6, 2025 · Form 4 insider transaction
Schacterle Amy bought 8,800 shares of Acumen Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
8,800
Price
$0.00
Total value
N/A
InsiderSchacterle Amy
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 6, 2025
Filing dateJanuary 7, 2025
Shares owned after8,800
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date.